Drug profile · INN
niraparib tosilate hydrate
ZEJULA
niraparib tosilate hydrate (ZEJULA) is a poly [adp-ribose] polymerase 2 inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 8
News articles 0
Drug details — niraparib tosilate hydrate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 8
- Data quality
- 0.78
Quick answer
niraparib tosilate hydrate (ZEJULA) is a poly [adp-ribose] polymerase 2 inhibitor.
Key facts
INN niraparib tosilate hydrate
Brand ZEJULA
Mechanism Poly [ADP-ribose] polymerase 2 inhibitor
Target Poly [ADP-ribose] polymerase 2
Mechanism of action
Poly [ADP-ribose] polymerase 2 inhibitor
Primary target: Poly [ADP-ribose] polymerase 2
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is niraparib tosilate hydrate?
niraparib tosilate hydrate (ZEJULA) is a poly [adp-ribose] polymerase 2 inhibitor.
What is the brand name for niraparib tosilate hydrate?
ZEJULA is a marketed brand name for niraparib tosilate hydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.